Carmine Circelli

Carmine Circelli is British Patient Capital’s Investor Director for Microbiotica and is also Director of Direct Life Science Investments at British Patient Capital, the commercial subsidiary of the British Business Bank, the UK government’s economic development bank.

Carmine has more than seven years of investment experience in the life sciences and software sectors from early to late stage. He also has experience in drug development, scientific sales and patent commercialisation.

Carmine holds a BSc in Pharmacology and a PhD in Cardiovascular Medicine from the University of Manchester.